Invited Lectures
- Exploring the Protein Plasticity of the Human Farnesyl Pyrophosphate Synthase - Therapeutic Implications
Department of Chemistry, University of Toronto (Toronto, Ontario, August 20, 2012)
- Exploring the Protein Plasticity and Therapeutic Value of Prenyl Synthase Enzymes Protein Plasticity and its Role in Inhibiting Human FPPS - Therapeutic Implications
Department of Chemistry and Pharmaceutical Sciences, Ludwig-Maximilians-Universität (Munich, Germany April 2012)
- Novel Inhibitors of Prenyl Synthase Enzymes as Potential Therapeutics
12th Eurasia Conference on Chemical Sciences (Corfu, Greece, April 2012)
- Novel Active Site Inhibitors of Prenyl Synthase Enzymes as Potential Therapeutics
Chemistry Department, University of Uppsala (Uppsala, Sweden, February 2012)
- New Challenges in Drug Discovery: are Prenyl Synthase Enzymes Good Therapeutics Targets ?
Department of Chemistry, University of Waterloo (Waterloo, Ontario, May 2011)
- Design and Synthesis of Molecular Tools that Modulate Metabolic Pathways
Department of Biochemistry, McGill University (Montreal, May 2010)
- Challenges in Drug Discovery and the Role of Academic Research
Chemical Biology Workshop; Department of Biochemistry, McGill University (Montreal, May 2009)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
College of Pharmacy, University of New England (Portland, Maine, November 2008)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Department of Chemistry, McGill University (Montreal, December 2008)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Ironwood Pharmaceuticals (Cambridge, Massachusetts, December 2008)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Department of Pharmaceutical Sciences and Chemistry, Ludwig-Maximilians-Universität (Munich, Germany, April 17, 2008)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Chemistry Department, Ottawa-Carleton University (Ottawa; November, 2007)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Archibald Macallum Lecture, Biochemistry Department, McGill University (Montreal, November 2007)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Brisbane Biological and Organic Chemistry Symposium (Institute for Molecular Biosciences, The University of Queensland, Australia; December 2007)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Ottawa-Carleton University (Ottawa; November 2005)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
GNF Institute, San Diego (USA; April 2005)
- The Design and Synthesis of Macrocyclic BILN 2061, a Potent Inhibitor of the Hepatitis C Virus: from the NMR Tube to the Clinic.
29th National Medicinal Chemistry Symposium (Madison, Wisconsin, USA; June 2004)
- The design and Synthesis of BILB 2061, a Potent Inhibitor of the Hepatitis C Virus: from the NMR Tube to the Clinic
9th Naples Workshop on Bioactive Peptides (Anacapri, Italy; May 2004)
- Design and Synthesis of Macrocyclic Inhibitors of Hepatitis C Virus; from the NMR Tube to the Clinic
Charité Universiatsmedizin, Berlin (Germany; August 2004)
- Current Therapies and Future Hopes for the Treatment of Hepatitis C
Queen’s University, Chemistry Department (March 3, 2004)
- Design and Synthesis of Macrocyclic Inhibitors of Hepatitis C Virus; from the NMR Tube to the Clinic
ETH Zentrum, Zuerich, Switzerland (April 24, 2003)
- Design and Synthesis of Macrocyclic Inhibitor of the Hepatitis C Virus: from the NMR Tube to the Clinic
Frontiers in Chemical & Structural Biology (Montreal, Quebec; April 2003)
- Design and Synthesis of Macrocyclic Inhibitors of Hepatitis C Virus; from the NMR Tube to the Clinic
McGill University, Biochemistry Department (Montreal, Quebec; February 2003)
- Design and Synthesis of Macrocyclic Inhibitors of Hepatitis C Virus; from the NMR Tube to the Clinic
McGill University, Chemistry Department (February 7, 2003)
- Novel Macrocyclic Inhibitors of the HCV NS3 Protease as Potential Therapeutic Agents of Hepatitis C Infections
9th International Symposium on HCV and Related Viruses (San Diego, CA; July 2002)
- Solid Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease
32nd Spring Synthesis Symposium of Ottawa - Carleton Chemistry (Ottawa; May 2002)
- Solid Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease
Cambridge Health Institute Conference on Molecular Diversity and High-Throughput Organic Synthesis (San Diego, CA; February 2002)
- Design and Synthesis of Macrocyclic Inhibitors of Hepatitis C Virus; from the NMR Tube to the Clinic
State University of New York, Stony Brook, Chemistry Department (NY, November 8, 2002)
- Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infections
Dalhousie University, Chemistry Department (October 4, 2002)
- Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infections
Acadia University, Chemistry Department (October 3, 2002)
- Peptidomimetics as Antiviral Agents
Gordon Research Conference on Bioorganic Chemistry, Proctor Academy, Andover, NH, USA (June 2001)
- Aromatic Peptide Nucleic Acids: A Paradigm of Nucleic Acids
84th CSC Conference and Exhibition (Montreal, Quebec; May 2001)
- Peptidomimetics as Antiviral Agents
Simon Fraser University, Chemistry Department (April 2001)
- Peptidomimetics as Antiviral Agents
The University of Western Ontario, Chemistry Department (February 2001)
- Peptidomimetics as Antiviral Agents
Queen’s University, Chemistry Department (March 20, 2001)
- Synthesis and Physicochemical Properties of a Novel Class of Peptide Nucleic Acids
International Chemical Congress 2000 of the Pacific Basin Societies (Honolulu, Hawaii; December 2000)
- Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Viral NS3 Protease of Hepatitis C
Gordon Research Conference on Bioorganic Chemistry, Proctor Academy, Andover, NH, USA (June 23, 2000)
- Gene Expression: New Tools in Drug Discovery
Queen’s University, Department of Chemistry (March 27, 2000)
- Gene Expression: New Tools in Drug Discovery
Guelph University, Department of Chemistry and Biochemistry (December 7, 1999)
- Gene Expression: New Tools in Drug Discovery
McMaster University, Department of Chemistry (December 6, 1999)
- Peptides as Biochemical Modulators of Gene Expression
Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Connecticut (February 9, 1999)
- Combinatorial Biosynthesis and its Role in Molecular Diversity
Phytochemical Society of North America 34th Annual Conference (July 11, 1999)
- Molecular Recognition in Biopolymers
BioChem Pharma, BioChem Therapeutics Inc. (June 23, 1998)
- Learning to Control Gene Expression: a New Tool in Drug Development
University of California at Davis, Chemistry Department (February 5, 1998)
- Structural Analysis of the Complex Natural Product Verucopeptin and Investigation of its
Biosynthetic Origin by 13C 1D-COSY and 1D-INADEQUATE NMR Experiments
43rd International Conference on Analytical Sciences & Spectroscopy. McGill University, Montreal, Quebec (August 1997)
- Biosynthetic Origin of the Tetrahydropyranyl Side Chain of Verucopeptin
5th US-Japan Seminar on Biosynthesis of Natural Products. Winthrop, Washington, USA (June 1997)
- Combinatorial Biosynthesis and its Role in Molecular Diversity
Bio-Méga / Boehringer Ingelheim Research Inc. (September 30, 1997)
- Oligopeptides and Oligoketides as Biochemical Modulators
Université du Québec à Montréal, Chemistry Department (March 20, 1996)
- Some Aspects of Molecular Recognition: Depsipeptides, Enzymes and Enzyme Mimics
Bio-Méga / Boehringer Ingelheim Research Inc. (February 12, 1996)
- Depsipeptides and Polyketides as Biochemical Modulators
Brown University, Chemistry Department, Providence, RI (June 15, 1995)
- Biosynthesis of the Fungal Metabolite Oudenone
PACIFICHEM'95 Conference, Honolulu, Hawaii (December 1995)
- Biochemical Modulators: Oligoketides and Oligopeptides
3rd Canadian Workshop in Organic Chemistry, Guelph, Ontario (May 1995)
- Genotoxins and Biochemical Modulators from Fungal Metabolites
Institut Armand-Frappier, Laval, Québec, Canada (December 20, 1994)
- Novel Biochemical Modulators from Fungal Metabolites
Ottawa-Carleton Chemistry Institute, Ottawa (September 27, 1993)
- Chemical Education in the Golden Age of Biotechnology
19th Annual Conference of College Chemistry in Canada, Vanier College (June 5, 1992)
- Mechanistic Studies on Sesquiterpene cyclase enzymes using Anomalous Substrates
McGill University, Chemistry Department (October 18, 1991)
- Fungal Metabolites : Isolation, Applications and Biosynthesis
Merck Sharpe & Dohme Research Laboratories, Rahway, N.J., USA (May 17, 1991)
- Microbial Metabolites in Plant Biotechnology
Wellesley College, Wellesley, Massachusetts, USA (June 27, 1991)
- Fungal Metabolites in Forestry and Agriculture
Université du Québec à Montréal, Department of Chemistry (November 1990)
- Antifungal Antibiotics from Pisolithus tinctorius
The Canadian Pacific Symposium on Plant Biotechnology, University of Saskatchewan, Saskatoon (August 1989)
- Popularizing Science
Montreal College Chemistry Symposium, Dawson College, Montreal, Quebec (June 1986)
- The Chemistry of Flowers
11th Annual Conference of College Chemistry Canada John Abbott College, Sainte Anne de Bellevue, Quebec (June 1984)